RU2018110031A - METHOD OF TREATMENT AND PREVENTION OF INFLUENZA - Google Patents

METHOD OF TREATMENT AND PREVENTION OF INFLUENZA Download PDF

Info

Publication number
RU2018110031A
RU2018110031A RU2018110031A RU2018110031A RU2018110031A RU 2018110031 A RU2018110031 A RU 2018110031A RU 2018110031 A RU2018110031 A RU 2018110031A RU 2018110031 A RU2018110031 A RU 2018110031A RU 2018110031 A RU2018110031 A RU 2018110031A
Authority
RU
Russia
Prior art keywords
influenza
prevention
treatment
influenza virus
methods
Prior art date
Application number
RU2018110031A
Other languages
Russian (ru)
Other versions
RU2018110031A3 (en
Inventor
Евгений Степанович Важинский
Original Assignee
Евгений Степанович Важинский
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Евгений Степанович Важинский filed Critical Евгений Степанович Важинский
Priority to RU2018110031A priority Critical patent/RU2018110031A/en
Publication of RU2018110031A publication Critical patent/RU2018110031A/en
Publication of RU2018110031A3 publication Critical patent/RU2018110031A3/ru

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)

Claims (1)

Способ лечения и профилактика гриппа содержащий методы, при котором сначала провоцируется вегетативное развитие вируса гриппа, как народными средствами, так и медикаментозным методами, отличающийся тем, чтобы уничтожить вирус гриппа в организме человека подвергаем его кислородному голоданию, как самостоятельно, так и с применением больничного стационара.A method for the treatment and prevention of influenza containing methods in which the vegetative development of the influenza virus is first provoked, both by folk remedies and by drug methods, characterized in that to destroy the influenza virus in the human body, subject it to oxygen starvation, both independently and with the use of a hospital .
RU2018110031A 2018-03-21 2018-03-21 METHOD OF TREATMENT AND PREVENTION OF INFLUENZA RU2018110031A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2018110031A RU2018110031A (en) 2018-03-21 2018-03-21 METHOD OF TREATMENT AND PREVENTION OF INFLUENZA

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2018110031A RU2018110031A (en) 2018-03-21 2018-03-21 METHOD OF TREATMENT AND PREVENTION OF INFLUENZA

Related Child Applications (1)

Application Number Title Priority Date Filing Date
RU2019119470A Division RU2019119470A (en) 2019-06-20 2019-06-20 DEVICE FOR TREATMENT AND PREVENTION OF INFLUENZA VIRUS OXYGEN STARVING

Publications (2)

Publication Number Publication Date
RU2018110031A true RU2018110031A (en) 2019-09-23
RU2018110031A3 RU2018110031A3 (en) 2019-09-23

Family

ID=68083800

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018110031A RU2018110031A (en) 2018-03-21 2018-03-21 METHOD OF TREATMENT AND PREVENTION OF INFLUENZA

Country Status (1)

Country Link
RU (1) RU2018110031A (en)

Also Published As

Publication number Publication date
RU2018110031A3 (en) 2019-09-23

Similar Documents

Publication Publication Date Title
JP2016034978A5 (en)
EA201791333A1 (en) GLUCAGON DERIVATIVES WITH IMPROVED STABILITY
HRP20201069T1 (en) Administration of tasimelteon under fasted conditions
EA201690069A1 (en) THE USE OF HIGH DOSE PRIDOPIDINE FOR THE TREATMENT OF THE HANTINGTON'S DISEASE
RU2017112747A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING A DEXTROMETORPHANIC COMPOUND AND QUINIDINE FOR THE TREATMENT OF EXCITATION IN DEMENIUM
JP2013155188A5 (en)
AR089862A1 (en) USE OF LAQUINIMOD FOR THE TREATMENT OF PATIENTS WITH CROHN'S DISEASE IN THOSE WHO FAILS AN ANTI-FACTOR THUMOR NECROSIS THERAPY a (ANTI-TNFa) FIRST LINE
RU2018125622A (en) METHOD OF APPLICATION OF CARRYMICIN AGAINST RESISTANCE OF INFECTION PROVIDED BY MYCOBACTERIA TUBERCULOSIS
EA202090242A1 (en) TREATMENT OF FABRY DISEASE IN FZT-NAIVE AND FZT-TREATED PATIENTS
BR112014031154A2 (en) prophylactic and / or therapeutic agent for mild cognitive impairment; and interstitial flow enhancing agent
NI201700024A (en) ANAMORELIN-BASED MEDICAL TREATMENTS
EA201691656A2 (en) THERAPEUTIC WAYS WITH THE USE OF NORIBOGOGINE AND RELATED COMPOUNDS
RU2018110031A (en) METHOD OF TREATMENT AND PREVENTION OF INFLUENZA
RU2015131803A (en) GLUTARIMID DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON THEM, METHODS FOR PRODUCING THEM
EA201892350A1 (en) PREPARATION FOR INHALATION ON THE BASIS OF ISOGLYCYRRISINIC ACID OR ITS SALT AND ITS APPLICATION IN THE OBTAINING OF MEDICINES FOR TREATING DISEASES OF THE RESPIRATORY SYSTEM
EA202090452A1 (en) COMPOUNDS FOR TREATMENT OF DISEASE VON HIPPEL-LINDAU
TH167851B (en) (S) - Perlindole And its pharmaceutical acceptable salt for Use in medicine
EA201991119A1 (en) PHARMACEUTICAL COMPOSITION, METHODS OF TREATMENT AND ITS APPLICATION
EA201692163A1 (en) MEDICINE FOR THE TREATMENT OF PATIENTS WITH TINNITUS
Furuta Drug allergy and bronchial asthma: 2 case reports
Fabiny Ask the doctor. I recently took antibiotics to treat an oral infection and as a result developed a vaginal yeast infection. Can I treat it myself, and what are the most effective options?
Berman Compartment syndrome following extravasation: case report
Grishina Studying of need for application of donor blood components in medical care
Svetlichnaya et al. CHARACTERISTICS OF INTERACTION BETWEEN DOCTOR AND PATIENT IN PSYCHIATRY
TH167851A (en) (S) - Perlindole And its pharmaceutical acceptable salt for Use in medicine